Stock A064550 BIONEER CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bioneer Corporation

Equities

A064550

KR7064550007

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
30,450 KRW +1.67% Intraday chart for Bioneer Corporation +0.16% -8.56%
Mar. 20 Bioneer Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 AFCAGRO Biotech Limited Enters into an Agreement with Bioneer Corporation to Produce Molecular Diagnostic Kits CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 153,241 151,153 446,094 1,254,380 758,823 859,483
Enterprise Value (EV) 1 156,966 153,580 406,748 1,192,774 706,658 812,290
P/E ratio -17.4 x -18.8 x 7.38 x 45.3 x 62.8 x -81.2 x
Yield - - - - - -
Capitalization / Revenue 6.36 x 4.16 x 2.16 x 5.61 x 3.47 x 3.27 x
EV / Revenue 6.52 x 4.23 x 1.97 x 5.33 x 3.24 x 3.09 x
EV / EBITDA -23.6 x -47.3 x 3.68 x 22.5 x 37.6 x 83.5 x
EV / FCF -34.5 x 38.3 x -425 x -46.7 x -38.7 x 99.9 x
FCF Yield -2.9% 2.61% -0.24% -2.14% -2.58% 1%
Price to Book 4.04 x 4.98 x 3.06 x 6.18 x 3.22 x 3.84 x
Nbr of stocks (in thousands) 20,625 22,261 25,132 25,810 25,810 25,810
Reference price 2 7,430 6,790 17,750 48,600 29,400 33,300
Announcement Date 3/19/19 3/19/20 3/19/21 3/18/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 24,078 36,292 206,987 223,744 218,394 263,237
EBITDA 1 -6,644 -3,249 110,599 52,921 18,814 9,726
EBIT 1 -11,634 -8,521 105,223 47,066 10,744 772.7
Operating Margin -48.32% -23.48% 50.84% 21.04% 4.92% 0.29%
Earnings before Tax (EBT) 1 -10,010 -6,373 55,650 43,278 13,904 -67
Net income 1 -8,818 -7,827 57,899 27,160 12,077 -10,587
Net margin -36.62% -21.57% 27.97% 12.14% 5.53% -4.02%
EPS 2 -427.6 -361.0 2,406 1,073 467.9 -410.2
Free Cash Flow 1 -4,551 4,009 -956.2 -25,516 -18,257 8,133
FCF margin -18.9% 11.05% -0.46% -11.4% -8.36% 3.09%
FCF Conversion (EBITDA) - - - - - 83.63%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/19/19 3/19/20 3/19/21 3/18/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales - 49.79 56.03 - -
EBITDA - - - - -
EBIT - -3.072 -0.103 - -
Operating Margin - -6.17% -0.18% - -
Earnings before Tax (EBT) - - - - -
Net income 1 8.65 -5.93 -0.467 16.55 0.476
Net margin - -11.91% -0.83% - -
EPS 335.0 -230.0 - - -
Dividend per Share - - - - -
Announcement Date 11/11/22 2/27/23 4/28/23 10/20/23 11/13/23
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 3,726 2,427 - - - -
Net Cash position 1 - - 39,346 61,606 52,165 47,193
Leverage (Debt/EBITDA) -0.5608 x -0.7469 x - - - -
Free Cash Flow 1 -4,551 4,009 -956 -25,516 -18,257 8,133
ROE (net income / shareholders' equity) -26.5% -21% 65.8% 16.4% 6.7% -2.89%
ROA (Net income/ Total Assets) -11.2% -6.97% 48.1% 13% 2.39% 0.16%
Assets 1 78,527 112,358 120,292 209,393 504,612 -6,734,752
Book Value Per Share 2 1,839 1,364 5,794 7,867 9,144 8,674
Cash Flow per Share 2 195.0 213.0 1,300 1,914 1,699 1,881
Capex 1 3,697 4,412 54,516 42,177 17,460 4,660
Capex / Sales 15.36% 12.16% 26.34% 18.85% 7.99% 1.77%
Announcement Date 3/19/19 3/19/20 3/19/21 3/18/22 3/21/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
BIONEER CORPORATION Stock Bioneer Corporation
-8.56% 570M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+2.93% 106B
ARGENX SE Stock argenx SE
+7.02% 23.47B
BIONTECH SE Stock BioNTech SE
-14.60% 21.9B
GENMAB A/S Stock Genmab A/S
-7.05% 18.77B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.55% 17.85B
BEIGENE, LTD. Stock BeiGene, Ltd.
-8.83% 16.78B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.51% 14.41B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.49% 12.86B
VIKING THERAPEUTICS, INC. Stock Viking Therapeutics, Inc.
+329.39% 8.78B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. A064550 Stock
  4. Financials Bioneer Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW